A Modern Landscape
of Non-Insulin Type 2 Diabetes Therapies
Originally presented Sunday, June 5, 2022
Available for on-demand viewing
Symposium held in conjunction with The American Diabetes Association’s 82nd Scientific Sessions
This symposium focuses on the evolving non-insulin treatment landscape for type 2 diabetes starting with a presentation of current treatments and disease state considerations followed by a multidisciplinary panel discussion of hypothetical patient cases from the perspective of an endocrinologist, a primary care provider, and a diabetes educator.
Our Team of Panelists
John Anderson
MD, FACE
Davida Kruger
MSN, APN, BC-ADM
Juan Pablo Frias
MD
On-demand Symposium Content
A Modern Landscape of Non-Insulin Type 2 Diabetes Therapies: Journeying through the options
Learning Objectives
- Review epidemiology and health burden of T2D and its key metabolic abnormalities
- Discuss the challenges and impact associated with therapeutic inertia and the importance of early glycemic control due to the progressive nature of T2D
- Provide an overview of the evolving therapeutic landscape that could improve overall outcomes for patients
- Apply therapeutic options to hypothetical patient cases through a panel discussion
Presentation content is not approved for continuing education credit
VV-OTHR-US-DEL-1087 07/2022 © Lilly USA, LLC 2022. All rights reserved.
This site is intended for US Healthcare Professionals only.
